98%
921
2 minutes
20
Restriction-modification (RM) systems are widespread defense mechanisms in prokaryotes that protect the host from potentially harmful foreign DNA. They typically consist of a DNA methyltransferase (MTase), which methylates the host genome at an adenine (6 mA methylation) or cytosine (4mC or 5mC), and a restriction endonuclease (REase), which cleaves foreign, unmethylated DNA. In addition to the 2023 published family of 5mC-MTases, an HgaI-homolog RM system was detected in Mycoplasma hominis with the more rare constellation of two 5mC MTase genes, called RM.MhoVI. A qPCR screening of 239 randomly selected M. hominis isolates revealed a prevalence of the MhoVI-RM system of 12.97% (n = 31/239). Notably, in all tested MhoVI-positive isolates, the MhoVI-RM cassette localized between MHO_3110 and MHO_3120 and comprised an XRE-family transcriptional regulator gene in addition to the RM genes. Intra-species conservation of the encoded MhoVI-enzymes was high (> 99% identities), and inter-species conservation was the lowest compared to the eponymous species Haemophilus gallinarum (46.6% M1.MhoVI; 48.1% M2.MhoVI; 27.4% R.MhoVI). A polycistronic organization of the MhoVI-genes was strongly suspected due to the discovery of gene-overlapping mRNA regions. The MTases activity was demonstrated in RM.MhoVI positive M. hominis isolates by protection of genomic DNA from cleavage by the methylation-sensitive endonuclease HgaI; and bioinformatics analysis using the Dorado basecaller on the Oxford Nanopore sequenced genomes revealed methylation rates of the respective motifs, 5'-GACGC-3'/5'-GCGTC-3', above 95% in MhoVI-positives, with a higher methylation frequency of 5'-GACGC-3' than 5'-GCGTC-3 in most isolates. A final proof of MhoVI-RM representing an HgaI-RM-like methylation activity was demonstrated through expression and analysis of recombinant rM2.MhoVI in E. coli.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12376442 | PMC |
http://dx.doi.org/10.1186/s12866-025-04270-3 | DOI Listing |
Infect Drug Resist
August 2025
Department of Clinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, 312000, People's Republic of China.
Background: commonly colonizes the genitourinary tract and primarily affects immunocompromised individuals. It is mostly confined to localized infections, with bloodstream dissemination being rare. Because of its fastidious nutritional requirements, the organism is seldom recovered by routine blood culture, and the absence of a cell wall renders it intrinsically resistant to many first-line antimicrobials.
View Article and Find Full Text PDFFront Parasitol
August 2025
Department of Biomedical Science, University of Sassari, Sassari, Italy.
Introduction: Trichomoniasis, the most common non-viral sexually transmitted disease, is caused by the protozoon . can establish a symbiosis with two bacteria, and Mycoplasma girerdii, whose intracellular presence may modulate several characteristics of the protozoan, including its sensitivity to 5-nitroimidazoles, the only class of drugs currently effective in treating trichomoniasis. The rising prevalence of strains resistant to metronidazole, the most commonly used antitrichomonal drug, underscores the need for therapeutic alternatives active against the protozoon.
View Article and Find Full Text PDFBMC Microbiol
August 2025
Institute of Med. Microbiology and Hospital Hygiene, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Restriction-modification (RM) systems are widespread defense mechanisms in prokaryotes that protect the host from potentially harmful foreign DNA. They typically consist of a DNA methyltransferase (MTase), which methylates the host genome at an adenine (6 mA methylation) or cytosine (4mC or 5mC), and a restriction endonuclease (REase), which cleaves foreign, unmethylated DNA. In addition to the 2023 published family of 5mC-MTases, an HgaI-homolog RM system was detected in Mycoplasma hominis with the more rare constellation of two 5mC MTase genes, called RM.
View Article and Find Full Text PDFEur J Clin Microbiol Infect Dis
August 2025
Department of Neurology, Liaoning Provincial People's Hospital, Shenyang, Liaoning Province, 110016, China.
Objective: To investigate the diagnostic and therapeutic approaches for M. hominis induced CNS infections in non-neonatal patients, raise clinical awareness, and provide insights for managing such cases.
Methods: A retrospective analysis was performed on the clinical presentation, laboratory findings, treatment, and prognosis of an adult meningitis case caused by M.
Vaccines (Basel)
June 2025
Clinical Academic Department of Women's Health, CF "University Medical Center", Astana 010000, Kazakhstan.
: Vaginal microbiota has emerged as an important factor influencing human papillomavirus (HPV) persistence and host immunity. While HPV infection is often transient, persistent infections with high-risk HPV genotypes significantly increase the risk of cervical carcinogenesis. Thus, this study aims to investigate the association between microflora/sexually transmitted infections (STIs) and HPV infection, with a focus on the prevalence of coinfection and the potential role of genital tract microecological disorders.
View Article and Find Full Text PDF